Abstract
Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee- Letter to the Editor & Author Response
Highlights
1) The authors have used high molecular weight hyaluronic acid (2.4-3.6 MDa) in concentration of 10mg/ml, ie 1% w/v (Eufflexa-Ferring 10mg/ml HA) and HA has been used with PRP in the ratio of 1:2.5
The sample size of the study seems inadequate for it to be labelled as an RCT as per CONSORT guidelines
Considering the absence of a true control group (Saline Placebo), and as both HA and PRP are established as treatment modalities in relieving pain in Knee OA, the sample size should have been larger to demonstrate a significant difference between the treatment groups
Summary
1) The authors have used high molecular weight hyaluronic acid (2.4-3.6 MDa) in concentration of 10mg/ml, ie 1% w/v (Eufflexa-Ferring 10mg/ml HA) and HA has been used with PRP in the ratio of 1:2.5. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have